𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic characterization of dehydroevodiamine in the rat brain

✍ Scribed by Sung-Hoon Ahn; Seng-Ho Jeon; Takashi Tsuruo; Chang-Koo Shim; Suk-Jae Chung


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
130 KB
Volume
93
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


The objective of this study was to examine the kinetics of the distribution of dehydroevodiamine (DHED) in the rat brain. After an intravenous infusion of 15 min (dose of 1-10 mg/kg), the temporal profiles of the plasma levels of DHED declined in a multiexponential manner. Moment analysis indicated that the clearance and steadystate volume of distribution for DHED were not statistically different with the dose, indicating that the pharmacokinetics for DHED is linear in the range examined. Nonlinear regression analysis of DHED concentrations in the plasma and the brain revealed that the linear kinetics into and out from the brain reasonably described the data and that the clearances for influx into and efflux from the brain were comparable. Transport clearances for DHED across MBEC4 monolayers, an in vitro model of the blood-brain barrier, were also comparable for influx and efflux, and were independent of the medium concentration. The concentration of DHED in cerebrospinal fluid was negligible compared with that found in plasma, indicating that the drug is not primarily distributed to the brain via the blood-cerebrospinal fluid barrier. These observations indicate that DHED is transported from the systemic circulation to the brain via the blood-brain barrier by linear kinetics.


πŸ“œ SIMILAR VOLUMES


Brain regional pharmacokinetics of biper
✍ Koichi Yokagawa; Emi Nakashima; Junko Ishizaki; Mitsuru Hasegawa; Hideki Kido; F πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 501 KB

## Abstract The pharmacokinetic profiles of biperiden (BP) in blood and in specific brain regions were investigated in rats after acute i.v. administration. The regional brain‐to‐blood unbound concentration ratios (__K__~pf~) were also determined after 16h intravenous infusion of BP. The __K__~pf~

Pharmacokinetics of P-glycoprotein inhib
✍ Stina SyvΓ€nen; Andrew Hooker; Obaidur Rahman; Helena Wilking; Gunnar Blomquist; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 338 KB

This article describes the experimental set-up and pharmacokinetic modeling of P-glycoprotein function in the rat blood-brain barrier using [ 11 C]verapamil as the substrate and cyclosporin A as an inhibitor of P-gp. [ 11 C]verapamil was administered to rats as an i.v. bolus dose followed by graded

Dose ranging pharmacokinetics and brain
✍ Sandrine Marchand; Marylore Chenel; Isabelle Lamarche; Claudine Pariat; William πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

The purpose of this study was to investigate the effect of dose on norfloxacin pharmacokinetics and distribution into the brain extracellular fluid (ECF), in freely moving rats. Unbound concentrations of norfloxacin in hippocampus were determined by microdialysis after an i.v. bolus dose of 12.5, 25

Linear pharmacokinetics of haloperidol i
✍ Y. F. Cheng; L. K. Paalzow πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 378 KB πŸ‘ 2 views

## Abstract Pharmacokinetics of haloperidol in the rat following intravenous bolus doses of 0Β·5, 1Β·0, and 2Β·5 mg kg^βˆ’1^, respectively, were investigated. It was found that haloperidol was a high extraction ratio drug with a total blood clearance averaging 83 ml min^βˆ’1^ kg^βˆ’1^. The volumes of distri